MSCI全球小型股指数调整在即 映恩生物-B等将被纳入

Core Viewpoint - MSCI announced the results of its quarterly index review for August 2025, with several companies, including InnoCare Pharma-B (09606), being added to the MSCI Global Small Cap Index, marking their entry into the "global asset" category [1] Group 1 - The adjustment will take effect after the market closes on August 26 [1] - Newly included companies will experience increased trading volume during the closing auction on the inclusion day due to passive fund buying [1] - While the short-term impact on stock prices is limited, the long-term benefits will be seen in terms of funding, valuation, and brand recognition [1]